Navigation Links
Inhaled Insulin Could Rock The Drug Market Soon

Following approval of Exubera, an oral insulin formulation by the U.S. Food and Drug Administration and the European Commission, the sales of the new treatment // modality is expected to soar in the next couple of months. The drug is a combined effort of three major pharmaceutical companies Sanofi-Aventis, Pfizer and Nektar Therapeutics.

The new formulation could eventually save the trouble of daily insulin injections for millions of diabetics worldwide. However, it cannot be viewed as a replacement as it may not be suitable for everyone.

Insulin, secreted by specialized cells of the pancreas plays a vital role in the maintenance of blood sugar levels. Diabetic individuals depend on insulin to maintain a balance. Poor blood sugar control over a prolonged time can lead to cardiovascular disease, kidney failure and stroke. In addition, it can impair the normal blood flow and vision.

Although insulin has been sold since 1920s, this new inhaled insulin form (powder that can be breathed inside using a mouthpiece) represents a major milestone in diabetic treatment. It is contraindicated in current smokers or in those who have stopped smoking for less than six months and patients with lung disease.

Pfizer would study the long-term effects of the new drug formulation shortly. Previous studies have established incidence of mild cough as a consequence of Exubera use. It is therefore recommended that all individuals who take the formulation undergo lung evaluation prior to use, which can be extended to every year following administration.

Apart from the above mentioned treatment regimen, the importance of diet, weight reduction and exercise should not be forgotten.


'"/>




Page: 1

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. The Effectiveness Of Inhaled Corticosteroids Studied
5. Inhaled nitric oxide therapy does not reduce death risk of infants
6. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
7. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
8. Inhaled Insulin To Be Made Available in India
9. High Cost Forces NHS To Reject Inhaled Insulin
10. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
11. Inhaled Insulin: A New Modality for Management of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... ... to enhance people’s everyday lives, recently attended the January ECRM Trade Show in ... Science is known for its large range of supplements that keep the body ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years of ... the clinical trial has been life-saving as she has been on the trial ... Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... ... You”: a fine examination of how God handles sin, including how to let go ... Miller, who, for over ten long years has been waiting to release this powerful insight ... he has been serving the Lord for over twenty years, and he has been preaching ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology: